SUMMARY
INTRODUCTION
The pituitary gland plays a fundamental role in regulating a wide variety of physiological functions, including growth, lactation, stress response, reproduction, and metabolism. These complex functions are regulated by six distinct hormone-producing cell types distinguished by the different hormones they synthesize and secrete, including corticotropes secreting adrenocorticotrophic hormone (ACTH), thyrotropes secreting thyroid-stimulating hormone (TSH), somatotropes secreting growth hormone (GH), lactotropes secreting prolactin (PRL), gonadotropes secreting luteinizing hormone (LH) and follicle-stimulating hormone (FSH), and melanotropes secreting melanocyte-stimulating hormone (MSH). During pituitary organogenesis, these lineages emerge in a stereotypical spatio-temporal pattern from a common ectodermal primordium, Rathke's pouch (RP) . Extensive studies in model systems have demonstrated that multiple signaling pathways, transcription factors, and cofactors define the genetic hierarchy that controls embryonic pituitary development (Davis et al., 2011; Kelberman et al., 2009; Zhu et al., 2007) .
We and others have shown previously that the evolutionarily conserved Notch signaling pathway plays an important role in early embryonic pituitary development (Kita et al., 2007; Raetzman et al., 2004 Raetzman et al., , 2007 Zhu et al., 2006) . Delta/Notch signaling, mediated by the critical transcription factor RBP-J, acts to prevent progenitor cells in the RP from premature differentiation through Hes1, one of the downstream target genes of the Notch pathway. It also controls the competence of progenitor cells by maintaining expression of the Prop1 gene, which encodes a pituitary-specific, paired-like homeodomain transcription factor necessary for the commitment of the PIT1 lineage of three cell types-somatotropes, thyrotropes, and lactotropes. In the absence of canonical Notch signaling, resulting from deletion of the Rbp-J gene at embryonic day (E) 10.5 in the RP using Pitx1-Cre transgenic mice, the progenitors adopt an early-born corticotrope cell fate at the expense of the latearising PIT1 lineage (Kita et al., 2007; Raetzman et al., 2007; Zhu et al., 2006) . Interestingly, the proliferating progenitors, residing in the periluminal region, are still present at the end of embryonic development in the mutant pituitary gland (Zhu et al., 2006) . However, the mutant animals died of cleft palate shortly after birth because of broad expression of Pitx1-Cre in the oral ectoderm (unpublished data) , leaving an open question regarding whether continued Notch signaling is required to maintain these pituitary progenitors in the postnatal period. Recently, it has been suggested that Notch signaling is required for progenitor maintenance based on deletion of the Notch2 gene in the embryonic RP. However, despite a progressive decrease in the number of pituitary progenitors, these cells remain in the postnatal gland in this animal model, particularly in the anterior lobe (Nantie et al., 2014 ). An animal model with specific and complete depletion of Notch signaling is required to provide an unambiguous answer.
At birth, all of the endocrine cell lineages are present in the mouse pituitary gland, but the gland continues to grow and mature substantially after birth, particularly during the first few postnatal weeks. It has been documented that this postnatal pituitary gland expansion in the rat is only partially brought about via proliferation of preexisting differentiated hormone-producing cells (Carbajo-Pérez and Watanabe, 1990; Taniguchi et al., 2000 Taniguchi et al., , 2001a Taniguchi et al., , 2001b Taniguchi et al., , 2002 . Double immunolabeling of hormone and proliferation markers reveals that 10%-30% of the proliferating cells are differentiated endocrine cells, implying that some of the postnatal proliferation might take place in undifferentiated cells. On the other hand, the mature pituitary gland has a low turnover rate under basal conditions (Florio, 2011) . However, one important feature of the pituitary gland is its plasticity. The cellular composition of the mature gland can change flexibly to adapt to the physiological or pathological demands of the organism (Levy, 2002) . Recently, postnatal pituitary stem cells have been identified based on expression of a variety of stem cell-specific markers, including SOX2, SOX9, E-Cadherin, NES, and the pituitary-specific transcription factor LHX3 (Chen et al., 2009; Fauquier et al., 2008; Garcia-Lavandeira et al., 2009; Gleiberman et al., 2008; Rizzoti, 2010; Vankelecom and Chen, 2014) . These cells are localized in the marginal region between the intermediate lobe and the anterior lobe, and, when cultured in vitro, they are capable of self-renewal and differentiation into diverse hormone-producing pituitary cell types, implying their ''stemness.'' In vivo characterizations of these SOX2 + cells have shown that they are most abundant in the neonatal pituitary gland . Recent studies of cell ablation of terminally differentiated cells have suggested that these SOX2 + cells may contribute to pituitary regeneration . In addition, lineage tracing of SOX2 + , SOX9 + cells have provided genetic evidence that these cells can contribute to organ homeostasis and tissue adaptation (Andoniadou et al., 2013; Rizzoti et al., 2013) . Expression of the Notch signaling component in postnatal stem cells has been described previously (Chen et al., 2006 (Chen et al., , 2009 Nantie et al., 2014; Tando et al., 2013; Vankelecom and Gremeaux, 2010) . Interfering with Notch activation affects stem cell number in pituitary primary culture, implicating a critical role of Notch signaling in stem cell proliferation (Chen et al., 2006; Nantie et al., 2014; Tando et al., 2013 
RESULTS

Notch Signaling Is Active in Pituitary Postnatal Stem Cells
Components of the Notch signaling pathway exhibit dynamic expression patterns during pituitary organogenesis. Their expression is high in the RP but becomes attenuated at E13.5 in the perspective anterior lobe as cells begin to undergo lineage commitment (Raetzman et al., 2004; Zhu et al., 2006) . However, we observed that the expression of Notch2, Dll1, Dll3, and the downstream target gene Hes1 persists in the periluminal region at E17.5, where the prospective postnatal pituitary stem cells reside ( Figure 1A ; . To further elucidate the status of Notch signaling in postnatal stem cells, we performed immunofluorescence staining using a specific anti-Hes1 antibody (Figure 1B) . All periluminal cells express SOX2 and E-Cadherin, and most of them express Hes1, suggesting that Notch signaling remains active in these cells. Double immunolabeling revealed that some of the SOX2 + stem cells co-expressed SOX9, LHX3, NES, and PROP1 (Figures 1C-1F ; Figures S1E-S1H). Interestingly, SOX9 appears to be more highly expressed in the periluminal layer next to the intermediate lobe, whereas LHX3 and PROP1 are more expressed toward the anterior lobe. These results, collectively, imply heterogeneity within the stem cell population.
Generation of the Prop1-Cre Transgenic Mice
To circumvent the neonatal lethality and early developmental defects in the Rbp-J f/f , Pitx1-Cre mice as described before (Zhu et al., 2006) , we generated a Cre line using the genetic information of the Prop1 gene to drive expression exclusively in the RP during pituitary organogenesis. We learned that the first intron of the Prop1 gene is essential for its expression based on the following observations. First, in the previously generated Prop1 knockout mice, where exons 2 and 3 and all introns were replaced with in-frame fusion of the LacZ cassette, LacZ failed to be expressed (Olson et al., 2006) . Second, the first intron of the Prop1 gene is evolutionally conserved and is required to maintain Prop1 gene expression in response to early Notch signaling (Zhu et al., 2006) . Consistent with these findings, it was shown later that the first intron of the Prop1 gene can function as a pituitary-specific enhancer when placed together with a heterogeneous promoter (Ward et al., 2007) . We mapped the critical region to a 2.2-kb promoter/enhancer region of the Prop1 gene, comprised of approximately 0.7 kb of promoter sequence, the first exon, and the first intron region (unpublished data). We subsequently generated Prop1-Cre transgenic mice using the same genomic information (Figure 1G ). This Cre line expresses CRE in many cells in the RP at E12.5, similar to endogenous PROP1 expression and, consistently, when crossed with Rosa26-LacZ reporter mice, can mediate LoxP recombination in many RP progenitors at E12.5, as evidenced by LacZ staining on whole mounts and sections ( Figures 1H and 1I ) and in almost all cells in the anterior and intermediate lobes of the pituitary gland at E14.5 and postnatal day (P) 0 ( Figure 1J ; Figure S1K ). The LacZ activity at E14.5 is almost identical to the expression pattern of LHX3 ( Figure 1K ), a critical transcription factor required for early pituitary development and expressed in every embryonic endocrine cell type and their precursors. Therefore, the Prop1-Cre line can effectively Figures 3C and 3D ). By P10, the periluminal pituitary stem cells as well as stem cell clusters in the anterior lobe, characterized by SOX2, SOX9, and E-Cadherin labeling, were almost completely absent in the mutant glands ( Figures 3E-3H ). Consistent with these observations, RNA levels of the Sox2, E-Cadherin, and Prop1 genes as well as the Notch downstream target Hes1 were downregulated in the mutant pituitary glands, detected by qRT-PCR ( Figure 3I ). Therefore, in the absence of Notch signaling after the onset of Prop1 expression in the RP, the SOX2 + progenitor cells in the RP fail to maintain selfrenewal, leading to a reduced population of proliferative progenitors and, consequently, a complete depletion of pituitary stem cells in the postnatal pituitary gland. As expected, the mutant mice were able to survive until adulthood. They were smaller than their age-matched wild-type controls by body weight ( Figures S3A and S3B) , and the pituitary glands of mutant animals were hypoplastic. Immunofluorescence staining revealed that all cell types in the anterior lobe were present but with a reduced number ( Figures 3J-3Q) . The intermediate lobe, labeled by POMC staining, which encloses the posterior lobe and separates the posterior lobe from the anterior lobe in wild-type glands, expanded laterally in the mutants, whereas the medial regions of the gland lacked intermediate lobe cells and, as a result, allowed direct contact between the anterior and posterior lobes (Figures 3P and 3Q Figure S3F ). Therefore, Notch activation in SOX2 + cells is necessary for their proliferation and maintenance.
S2A-S2D
Prop1 Functions Downstream of Sox2
It has been shown previously that expression of Prop1 in RP is directly regulated by Notch signaling (Nantie et al., 2014; Zhu et al., 2006 However, despite a progressively diminished postnatal stem cell population and decreased cell proliferation at P1, the mutant pituitary glands continued to proliferate and expand postnatally. At P10, the labeling index in the anterior lobe of the mutant gland is similar to that of the wild-type control, in contrast to P1, when a significant difference was observed ( Figure S4 ). To further examine the proliferation dynamics, we performed a double-thymidine analog incorporation assay by administering 5-chloro-2 0 -deoxyuridine (CldU) and 5- Figures 5A and 5B ), suggesting that, in contrast to the intestine or other organs with fast cell turnover, there were no transiently amplifying made up about 87% of the dividing cells in the anterior lobe in both the wild-type and mutants, and no transiently amplifying progenitor cells were detected ( Figures 5H-5N ).
To further characterize cell divisions in postnatal pituitary gland expansion, single IdU labeling at different postnatal time points was performed in wild-type animals. Immunofluorescence assays and further analyses revealed that the overall labeling index in the anterior lobe peaked at P3 and then decreased gradually ( Figure 5O ). Quantifications of dividing cells among SOX2 + and PIT1 + cells, respectively, revealed that the actively dividing SOX2 + stem cells declined significantly, transitioning from a highly proliferative state in the neonatal stages to near quiescence a few weeks after birth, whereas PIT1 + cells exhibited a temporally delayed wave of proliferation and became mostly quiescent as well ( Figures S5A and S5B ). In the process of postnatal expansion, PIT1 + cells gradually increased in cell number and, ultimately, represented large proportions of dividing cells in the mature pituitary gland ( Figure 5P ; Figure S5C ). To examine the contribution of SOX2 + cells in the postnatal pituitary gland, we carried out lineage tracing experiments using Sox2-Cre ERT2 , ROSA26-EYFP mice (Arnold et al., 2011) . Tamoxifen was injected for two consecutive days at P1 and P2, and animals were analyzed at P15. Consistent with observations from others (Andoniadou et al., 2013; Rizzoti et al., 2013) 
Roles of Pituitary Postnatal Stem Cells in Pituitary Plasticity
An interesting feature of the pituitary gland is its plasticity. The composition and cell content of the gland changes to meet the physiological demands. One example is that the number of lactotropes in the rat pituitary gland increases 3-fold during pregnancy and lactation (Levy, 2002) . It is generally believed that transdifferentiation and increased lactotrope proliferation account for this change, although, in the mouse, no lactotroph transdifferentiation has been observed during pregnancy and lactation (Castrique et al., 2010) . However, it is not known whether pituitary stem cells play a role in these processes. We therefore probed the possibility of whether pituitary stem cells, although mostly quiescent during their adult life, might reenter the cell cycle and function in these processes. We examined cell proliferation in the pituitary glands of wild-type pregnant females on days 13 and 18 of pregnancy and day 7 of lactation as well as in age-matched virgin females ( Figure 6 ). Overall, cell proliferation in the pituitary gland increased toward the end of pregnancy at E18.5 and while lactating at P7. Double labeling of SOX2/KI67 and PIT1/KI67 revealed that SOX2 + stem cells did not undergo enhanced proliferation under these conditions. In contrast, PIT1 + cells were still the major proliferating cells in the anterior lobe. Among them, only a very small number of PRL + KI67 + cells could be identified (Figure 6 ). Similar proliferation dynamics were observed in mutant pituitary glands ( Figure S6 ). These data suggest that SOX2 + stem cells remain mostly quiescent in these processes and are unlikely to play a significant role during pregnancy and lactation. This is consistent with our observation that the number and size of litters generated from mutant females were not significantly different from those of control wild-type females, and the mutant females did not exhibit any detectable defects in lactation (8.4 ± 0.9/litter for wild-type and 7.7 ± 0.9/litter for mutant animals, mean ± SEM, n = 3 litters, p = 0.12; data not shown). Therefore, we conclude that Notch signaling and Notch-dependent SOX2 + stem cells are not absolutely required for pituitary functions in the process of pregnancy and lactation. A second example of pituitary plasticity is characterized by the fact that there are increases in the number of proliferating cells and in the number of corticotropes in response to bilateral adrenalectomy (ADX) because of disruption of the negative feedback imposed by glucocorticoid from the target organ, the adrenal gland (Levy, 2002; Nolan and Levy, 2006) . qRT-PCR from wild-type pituitary glands after ADX showed increases in the RNA levels of Pomc and the proliferating marker Ki67 ( Figure 7A ). Interestingly, RNA levels of glucocorticoid receptor (GR) declined gradually, compatible with the idea that there is a disruption of negative feedback upon ADX. We questioned whether postnatal pituitary stem cells make up those proliferating cells after ADX in the pituitary gland. We performed surgery in wild-type animals. Double immunofluorescence labeling of SOX2/CldU in wild-type animals revealed that SOX2 + cells contributed to 2.2% of cells labeled with CldU in sham surgery, and the respective contribution changed to 6.9% upon ADX (Figures 7B-7F ). These data suggest that SOX2 + stem cells could be reactivated to proliferate by ADX. However, SOX2 + stem cells were not the only cell types that were stimulated to proliferate upon ADX. PIT1 + cells as well as ACTH + corticotropes also exhibited increased proliferation, with PIT1 + cells representing the majority of proliferating cells and ACTH + corticotropes representing a much lower proportion than SOX2 + cells ( Figures 7D, 7E , 7G, and 7H; data not shown). Consistently, GR expression was detected in PIT1 + cells ( Figure S7 ). These results suggest that ADXinduced cell proliferation in the pituitary gland is not cell type specific. We also performed similar experiments in both control littermates and the mutant mice. ADX induced an $3-fold increase in the number of cells incorporating CldU in the anterior lobe of wild-type pituitary glands. We did not detect a significant deficit in the responses to ADX in the mutant animals with respect to both the increase in the number of proliferating cells and the increase of ACTH + cells (Figures 7G-7K ). These results reveal that ADX can elicit general reactivation of multiple cell types in the pituitary gland and that SOX2 + stem cells make a limited contribution to the overall responses in the pituitary gland.
DISCUSSION
Adult stem cells have been identified in the postnatal pituitary gland. These are groups of heterogeneous cells expressing SOX2, SOX9, LHX3, PROP1, E-Cadherin, and NES located either in the marginal zone between the intermediate and anterior lobes or scattered in the anterior lobe (Chen et al., 2009; Fauquier et al., 2008; Garcia-Lavandeira et al., 2009; Gleiberman et al., 2008; Rizzoti, 2010; Vankelecom and Chen, 2014) . It has been suggested previously that mouse pituitary adult stem cells are uniquely set aside during embryonic pituitary development and only contribute prominently to postnatal pituitary growth (Gleiberman et al., 2008) . In this study, we showed that these stem cells were labeled by the LacZ or GFP reporters in the lineage-tracing experiment using the RP-specific Prop1-Cre line, suggesting that pituitary stem cells are derived from the embryonic RP progenitors and that they continue to proliferate and differentiate to contribute to postnatal pituitary expansion. One common feature of RP progenitors and postnatal stem cells is their expression of the transcription factor SOX2, which has been determined to be expressed in many adult stem cells (Andoniadou et al., 2013; Arnold et al., 2011; Rizzoti et al., 2013) . In this study, we demonstrate that postnatal pituitary SOX2 + stem cells are maintained by the canonical Notch signaling pathway. Our result is consistent with the finding that Notch signaling is essential for the long-term maintenance of neural stem cells in the adult brain hippocampus, where it has been shown that RBP-J is recruited to the Sox2 promoter and activates its expression (Ehm et al., 2010 ). In the absence of Notch signaling, the pituitary stem cells were depleted gradually in the postnatal pituitary gland. This was accomplished by employing Prop1-Cre, which is expressed in all RP progenitors, but not so early to interfere with the lineage commitment program, in which Notch signaling plays a pivotal role (Zhu et al., 2006 Figure S1L ; Davis et al., 2011) , whereas, after birth, these cells remain mitotically active for the initial 3 weeks and then become mostly quiescent after this period. For the first 3 days after Tissue homeostasis in the adult stage is maintained by different mechanisms. In fast turnover tissues, e.g., the intestine and epidermis, tissue maintenance is coordinated by tissue-specific stem cells through self-renewal and differentiation processes, whereas initial analysis in slow turnover tissue, e.g., the pancreas, tissue homeostasis can be largely mediated by replication of differentiated cells (Brennand and Melton, 2009; Simons and Clevers, 2011 (Andoniadou et al., 2013; Rizzoti et al., 2013) . In addition, we showed that, during pregnancy and lactation, SOX2 + cells are not mobilized readily and not essential for these processes. However, we found that SOX2 + cell can be re-activated following bilateral adrenalectomy when the negative feedback inhibition is eliminated, although they represent only a minor proportion of cells that were mobilized for proliferation, consistent with recent findings (Langlais et al., 2013; Rizzoti et al., 2013) . Indeed, ADX responses were not affected significantly in the absence of SOX2 + cells, suggesting that, although SOX2 + cells can be mobilized and make a limited contribution to corticotrope expansion (Rizzoti et al., 2013) , they are not an essential component for the functions of a mature gland under the conditions we examined. Interestingly, we observed that PIT1 + cells are also mobilized to proliferate under pregnancy/lactation, target organ ablation, and partial hypophysectomy (unpublished data) and that they constitute a rather large proportion of proliferating cells. These findings raise the intriguing possibility that PIT1 + cells, and potentially other cell types, may function as reserve cells and contribute to pituitary plasticity in response to physiological demands. Indeed, it has been demonstrated recently that differentiated cells of the stomach and lung can function as stem cells and give rise to various cell types of the tissues, revealing enormous plasticity of cells (Stange et al., 2013; Tata et al., 2013) . Whether and how PIT1 + cells and other cells in the pituitary gland respond to physiological demands and whether transdifferentiation is involved are interesting questions to be investigated.
EXPERIMENTAL PROCEDURES Mice
Prop1-Cre transgenic mice were generated by using the 2.2-kb promoter and enhancer region of the Prop1 gene to drive CRE recombinase expression. Rbp-J f/f mice were provided by Dr. T. Honjo (Tanigaki et al., 2002) . Sox2-Cre ERT2 (Arnold et al., 2011) , Rosa26-LacZ reporter Gt(ROSA)26Sor tm1Sor (Soriano, 1999) , Z/EG (Tg(CAG-Bgeo/GFP) (Novak et al., 2000) , and Rosa26-EYFP (Srinivas et al., 2001 ) mice were obtained from Jackson Laboratory. Noon of the day of the vaginal plug was considered E0.5. For lineage-tracing experiments, tamoxifen was injected at P1 and P2 at 0.075 mg/g. Care and experimentation were carried out in accordance with the Institutional Animal Care and Use Committee of University of California at San Diego.
CldU/IdU Labeling
For CldU and IdU labeling, the animals received one intraperitoneal injection of CldU for 1 day at noon, followed by a similar injection of IdU for 1 day (at 100 mg/g body weight), and were sacrificed 1 day after the last injection. For the postnatal labeling index experiment, the animals were injected with IdU at noon and sacrificed 2 hr later. CldU and IdU were obtained from Sigma. 
Cell Counting and Statistical Analysis
